Articles with public access mandates - Jin NakaharaLearn more
Not available anywhere: 1
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
JF Howard, S Bresch, A Genge, C Hewamadduma, J Hinton, Y Hussain, ...
The Lancet Neurology 22 (5), 395-406, 2023
Mandates: National Institute for Health Research, UK
Available somewhere: 7
Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys
Y Nagai, N Miyakawa, H Takuwa, Y Hori, K Oyama, B Ji, M Takahashi, ...
Nature neuroscience 23 (9), 1157-1167, 2020
Mandates: US National Institutes of Health
Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis
J Nakahara, K Kanekura, M Nawa, S Aiso, N Suzuki
The Journal of clinical investigation 119 (1), 2008
Mandates: US National Institutes of Health
Sex Differences in Blood Pressure–Lowering Therapy and Outcomes Following Intracerebral Hemorrhage
M Fukuda-Doi, H Yamamoto, M Koga, YY Palesch, VL Durkalski-Mauldin, ...
Stroke, 2020
Mandates: US National Institutes of Health
Dynamic alterations in the central glutamatergic status following food and glucose intake: in vivo multimodal assessments in humans and animal models
M Kubota, Y Kimura, M Shimojo, Y Takado, JMN Duarte, H Takuwa, ...
Journal of Cerebral Blood Flow & Metabolism 41 (11), 2928-2943, 2021
Mandates: Knut and Alice Wallenberg Foundation
A review of Bruton’s tyrosine kinase inhibitors in multiple sclerosis
L Airas, RA Bermel, T Chitnis, HP Hartung, J Nakahara, O Stuve, ...
Therapeutic Advances in Neurological Disorders 17, 17562864241233041, 2024
Mandates: Academy of Finland
Comprehensive Analysis of Long COVID in a Japanese Nationwide Prospective Cohort Study
H Terai, M Ishii, R Takemura, H Namkoong, K Shimamoto, K Masaki, ...
Mandates: Japan Science and Technology Agency
REMODEL I/II Trials: Efficacy, Safety, and Tolerability of Remibrutinib in Patients With Relapsing Multiple Sclerosis
H Wiendl, L Airas, T Chitnis, M Williams, J Nakahara, R Bermel, A Mann, ...
EUROPEAN JOURNAL OF NEUROLOGY 29, 219-220, 2022
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Publication and funding information is determined automatically by a computer program